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Neuropeptide S receptor 1 (NPSR1, GPRA 154, GPRA) has been verified as a susceptibility gene for asthma
and related phenotypes. The ligand for NPSR1, Neuropeptide S (NPS), activates signalling through NPSR1
and microarray analysis has identified Tenascin C (TNC) as a target gene of NPS-NPSR1 signalling. TNC
has previously been implicated as a risk gene for asthma. We aimed therefore to study the genetic associ-
ation of TNC in asthma- and allergy-related disorders as well as the biological and genetic interactions
between NPSR1 and TNC. Regulation of TNC was investigated using NPS stimulated NPSR1 transfected
cells. We genotyped 12 TNC SNPs in the cross-sectional PARSIFAL study (3113 children) and performed
single SNP association, haplotype association and TNC and NPSR1 gene–gene interaction analyses. Our
experimental results show NPS-dependent upregulation of TNC-mRNA. The genotyping results indicate
single SNP and haplotype associations for several SNPs in TNC with the most significant association to rhi-
noconjunctivitis for a haplotype, with a frequency of 29% in cases (P 5 0.0005). In asthma and atopic sensit-
ization significant gene–gene interactions were found between TNC and NPSR1 SNPs, indicating that
depending on the NPSR1 genotype, TNC can be associated with either an increased or a decreased risk of
disease. We conclude that variations in TNC modifies, not only risk for asthma, but also for rhinoconjuncti-
vitis. Furthermore, we show epistasis based on both a direct suggested regulatory effect and a genetic inter-
action between NPSR1 and TNC. These results suggest merging of previously independent pathways of
importance in the development of asthma- and allergy-related traits.
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INTRODUCTION
The neuropeptide S receptor (NPSR1 also GPRA or GPR154)
was recently identified as a susceptibility gene for asthma and
high total serum IgE levels (1–6). The ligand for NPSR1,
known as Neuropeptide S (NPS), activates signalling
through NPSR1 (7,8). To identify target genes of
NPS-NPSR1 signalling, a stable NPSR1-A overexpressing
cell line was engineered and the effect of NPS stimulation
on gene expression studied by microarray analysis (9). One
of the upregulated genes, showing a robust .4-fold change,
was Tenascin C (TNC).
TNC has been considered an important gene in asthma
pathogenesis for over 10 years, because it is abnormally upre-
gulated in asthmatic tissue (10). However, surprisingly little
genetic evidence has been put forward to support this bio-
marker (11) despite the existence of genetic variants with
potential functional differences. One genome-wide linkage
study linked the region on 9q33, where TNC is located, to
asthma (12) and recently a coding SNP (Leu1677Ile) was
reported to strongly associate to adult asthma (13). The
same region has, however, been considered as a candidate
region for genome-wide studies searching for linkage to aller-
gic rhinitis (14–16) even though no candidate genes have been
investigated so far. TNC, also known as hexabrachion, is an
extracellular matrix (ECM) protein functioning as an
adhesion-modulating molecule with main biological roles in
cell communication and signal transduction. TNC promotes
weak connections with its conjugating proteins and is believed
to be involved in cell migration and growth (17). The tenascin
family of glycoproteins display highly restricted expression
patterns and are found mainly during embryogenesis (18). In
adult tissue, tenascins are only expressed in pathological
states including inflammation, or in reparatory processes
such as wound healing (17,18). Several previous studies
have linked TNC expression to asthma and allergy both in
mouse (19,20) and in human (10,21–25). Recently, TNC
together with NPSR1 were highlighted as two most interesting
genes providing novel insights into asthma pathogenesis (11).
In complex disorders that have multiple susceptibility and
protective genes, there is a possibility of risk modification
depending on different allele combinations (epistasis or ‘gene-
gene interaction’). As both NPSR1 and TNC have been impli-
cated as risk factors for asthma, and since it has been
suggested that TNC may be regulated by NPSR1 activation,
our objective was to investigate the genetic role of TNC in
asthma- and allergy-related disorders as well as the potential
biological and genetic connection between NPSR1 and TNC.
Using stable NPSR1 transfected cells, stimulated with NPS
we investigated the mRNA expression pattern of TNC. We
studied the genetic role of TNC and also the effect of different
TNC and NPSR1 allele combinations using the cross-sectional
PARSIFAL (Prevention of Allergy-Risk factors for Sensitis-
ation In children related to Farming and Anthroposophic Life-
style) study. The PARSIFAL study includes children 5–13
years of age from five different European countries, well
characterized for asthma- and allergy-related traits (26). The
association of NPSR1 SNPs to asthma- and allergy-related
phenotypes in the PARSIFAL children has been reported
earlier (3).
In this study, we found that experimental NPS stimulation
of NPSR1 transfected cells upregulated TNC mRNA in a dose-
dependent manner. In the PARSIFAL study polymorphisms
within TNC were genetically associated to childhood
asthma- and allergy-related phenotypes, with the strongest
association to rhinoconjunctivitis, and there appears to be sig-
nificant epistasis between NPSR1 and TNC altering the risk of
disease.
RESULTS
NPS stimulation of NPSR1 regulates TNC mRNA
expression in a dose-dependent manner
To validate and extend previous microarray results, suggesting
a NPS-NPSR1 activation-dependent upregulation of TNC (9),
we stimulated NPSR1-A transfected HEK-293H cells for 6 h
with increasing concentrations of NPS (0.1, 1 and 5 mM).
The mRNA expression levels of TNC were measured using
quantitative reverse-transcriptase–PCR (qRT–PCR). The
relative TNC expression of the NPS-stimulated HEK-293H
cells, compared with unstimulated control HEK-293H cells,
increased in a dose-dependent manner up to 12 times more
at 5 mM NPS when compared with the unstimulated control
(Fig. 1). We also validated the results in a human lung epi-
thelial cell line (A549) transiently transfected with
NPSR1-A. The result showed an 3.3-fold (+ SD ¼ 0.3) upre-
gulation of TNC mRNA in cells stimulated with 0.1mM NPS
for 6 h, compared with unstimulated control A549 cells.
These results confirmed the regulation of TNC expression by
NPSR1 signalling.
In vivo co-expression of NPSR1 and TNC in asthmatic
bronchus
If there is biological connection in asthma between NPSR1
and TNC, the two proteins would likely be co-expressed in
Figure 1. Dose-dependent expression levels of TNC-mRNA after NPS stimu-
lation in concentrations 0.1, 1 and 5mM for 6 h of NPSR1-A transfected HEK
293H cells. The mRNA expression levels were measured by qRT-PCR in tri-
plicates. Relative expression levels of TNC in the stimulated NPSR1-A cells
were compared with the expression in unstimulated cells with GAPDH as
endogenous control (mean+SD).
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the asthmatic airway. Bronchial biopsy specimens from
healthy controls and asthmatic patients were stained with anti-
bodies against NPSR1 and TNC, and the expression of both
proteins was found elevated in asthmatic airways compared
with healthy controls (Fig. 2). The two proteins were found
in close proximity, with NPSR1 detectable in bronchial epi-
thelial cells (Fig. 2A) and TNC in the subepithelial basement
membrane zone (Fig. 2C).
Genetic association of TNC alleles to childhood
allergy- and asthma-related traits
With an attempt to replicate the previously suggested genetic
association of TNC to asthma-related disorders, we genotyped
children from the PARSIFAL study with 12 TNC SNPs
tagging redundantly the previously associated 30 part of the
gene. The genotyping results indicated single SNP associ-
ations between several SNPs in TNC and current rhinocon-
junctivitis, with the most significant associations to SNP
rs3789873 intron 10, rs13321 Gln2008Glu and rs1330363
intron 15 (Table 1). Similar results were found when restrict-
ing the analysis to allergic rhinoconjunctivitis (i.e. a combi-
nation of current rhinoconjunctivitis and the presence of IgE
antibodies to inhalant allergens), with the most significant
association for rs3789873 (OR ¼ 1.37, 95%CI ¼ 1.09–1.74,
P ¼ 0.008). Weaker associations were found for rs2297181
intron 16, to doctor’s diagnosis of asthma (OR ¼ 1.29,
95%CI ¼ 1.00–1.68, P ¼ 0.05) (for a complete report, see
Supplementary Material, Table S2A) and atopic sensitization
(OR ¼ 1.18, 95%CI ¼ 1.00–1.39, P ¼ 0.05). To test for a
more specific asthma phenotype we analysed those having
a doctor’s diagnosis of asthma combined with an atopic
sensitization, i.e. allergic asthma. These individuals showed
a stronger association to rs2297181 (OR ¼ 1.53, 95%CI ¼
1.10–2.13, P ¼ 0.01). Haplotype analysis revealed three
haplotype blocks (Fig. 3) with the most significant association
in block 1, showing haplotype-specific association for the
four-allele haplotype TGGT to current rhinoconjunctivitis
(Table 2), and also showing associations to atopic sensitization
(OR ¼ 1.17, 95%CI ¼ 1.02–1.33, P ¼ 0.03) and allergic
rhinoconjunctivitis (OR ¼ 1.47, 95%CI ¼ 1.15–1.87, P ¼
0.002). No significant association was found on the haplotype
level to doctor’s diagnosis of asthma (for a complete report,
see Supplementary Material, Table S2B) but the more strin-
gent phenotype allergic asthma revealed significant associ-
ation for the five-allele haplotype AACCC in block 3 (OR ¼
1.52, 95% CI ¼ 1.09–2.11, P ¼ 0.02). We also tested for
association to the extended haplotype grouping all 12 geno-
typed TNC SNPs. This full segment showed significant associ-
ation for the haplotype TGGT_G_GA_GGCCG to current
rhinoconjunctivitis (OR ¼ 1.47, 95%CI ¼ 1.17–1.84 p ¼
0.001), atopic sensitization (OR ¼ 1.16, 95%CI ¼ 1.02–
1.33, P ¼ 0.03) and allergic rhinoconjunctivitis (OR ¼ 1.45,
95%CI ¼ 1.13–1.86, P ¼ 0.004). Doctor’s diagnosis of
asthma did not show significant association to an extended
haplotype but allergic asthma showed significant association
for the haplotype CGCC_G_GA_GACTC (OR ¼ 1.44,
95%CI ¼ 1.00–2.06, P ¼ 0.05). No significant associations
were found on either single SNP or haplotype level for the
traits current wheezing or current atopic eczema.
NPSR1 and TNC alleles show epistatic effects on risks
Because TNC was regulated by NPSR1, and both TNC and
NPSR1 are independently associated to asthma- and
allergy-related phenotypes, we evaluated potential epistatic
effects between variants in the two genes (‘gene-gene inter-
actions’) in the PARSIFAL study population. The association
of NPSR1 SNPs to asthma- and allergy-related phenotypes
has been reported earlier for the PARSIFAL children (3) and
we used these data to analyse joint effects of TNC and
NPSR1 variants. Evidence of significant interaction was
Figure 2. Bronchial biopsy specimens from at least eight asthmatic patients (exemplified in A and C) and eight normal control subjects (exemplified in B and D)
were stained with antibodies against NPSR1-B (A and B) and TNC (C and D). NPSR1 immunoreactivity was detected in the epithelial cells in asthmatic patients
(A), whereas no NPSR1 protein was detected in control subjects (B). TNC immunoreactivity was visible in the sub epithelial basement membrane layer in asth-
matic patients (C) but not in control subjects (D). E, epithelium; arrowheads, basement membrane. Original magnification 250.
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found between several of the TNC and NPSR1 SNPs for atopic
sensitization or doctor’s diagnosis of asthma (Table 3). The
coding TNC SNP rs2104772, Leu1677Ile, in combination
with the NPSR1 SNPs rs323922 and rs324384, showed signifi-
cant interaction for both these traits (Table 3). However, no
significant interactions were seen between TNC and NPSR1
for the outcome current atopic eczema and only few
significant interactions were found for current rhinocon-
junctivitis (rs12347433rs324396; P ¼ 0.05) or current
wheezing (rs12347433rs323917; P ¼ 0.05, rs3789873
rs323917; P ¼ 0.02, rs1330362rs324384; P ¼ 0.03,
rs10817704 rs324384;P ¼ 0.01). Due to lack of power, no inter-
action analyses were performed on combined phenotypes. The
interaction analysis indicated that depending on the NPSR1
genotype, TNC variants can be associated with both an increased
and a decreased risk of disease, as illustrated graphically in
Figure 4 (for a complete report of odds ratios for all significant
interactions in relation to atopic sensitization or doctor’s diagno-
sis of asthma, see Supplementary Material, Table S3A and B).
DISCUSSION
In asthma and allergy as in many other complex disorders, risk
effects (estimated as ORs) of individual genes have turned out
to be notably lower than the estimated total genetic risk.
Therefore, it is possible that some combinations of risk
genes or of risk genes and environmental exposures might
interact and cause unexpected joint risk effects. To find such
possible genetic interactions, it is reasonable to start evaluat-
ing combinations of already identified risk-modifying genes.
A further useful consideration in searching for such epistatic
effects might be any known biological interactions. When
our previous microarray analysis suggested NPSR1-dependent
regulation of TNC, and both genes had been independently
associated with asthma or related phenotypes, it appeared
well-motivated to hypothesize that the two genes might also
show epistatic effect patterns.
By stimulating NPSR1 transfected HEK293H cells with
NPS, we demonstrated that the upregulation of TNC mRNA
is NPS dose-dependent, confirming and extending our pre-
vious suggestion of NPS-NPSR1-dependent regulation of
TNC (9). We could also show that the NPS-NPSR1 pathway
upregulates TNC mRNA in NPS-stimulated NPSR1 transiently
transfected human lung epithelial cells. In a recent study of
ovalbumin-induced bronchial asthma in TNC-deficient mice,
a lack of TNC attenuated allergen-induced bronchial asthma
(20). TNC has also been shown to be abundantly deposited
in the basement membrane (BM) zone of asthmatic bronchi
(10) and the same study indicates that the expression of
TNC is higher in patients with severe and chronic asthma.
Thus, TNC might be an important factor in the characteristic
incomplete healing and remodelling of the asthmatic
airways. As asthma and allergy prolong and get more severe
Figure 3. The 30 50 kb of TNC analysed in this study. The LD plot, as defined
by Gabriel et al. (48), divides TNC in three haplotype blocks 1, 2 and 3. The
studied SNPs in each block are indicated and also the relative position in the
TNC gene (white bar). The numbers in each box correspond to the pair-wise
linkage disequilibrium coefficient D0 between SNPs.
Table 1. Genetic association between TNC polymorphisms and current rhinoconjunctivitis in children from the PARSIFAL study
SNPa Position in gene (NT_008470) Minor allele frequency Risk allele OR (95% CI)b P-valueb,c
Cases, n ¼ 214d Controls, n ¼ 2849d
rs12351083 [T/C] 30genome 0.28 0.30 T 1.10 (0.88–1.37) 0.387
rs1330362 [G/A] 30genome 0.05 0.06 G 1.25 (0.78–2.01) 0.353
rs13321 [C/G] Gln2008Glu 0.33 0.27 G 1.34 (1.09–1.66) 0.006
rs12347433 [T/C] Arg1891Arg 0.27 0.29 T 1.11 (0.88–1.40) 0.389
rs2274750 [G/A] Thr1781Ala 0.03 0.02 A 1.27 (0.71–2.26) 0.417
rs10817704 [G/A] intron 17 0.03 0.05 G 1.76 (1.00–3.10) 0.046
rs2104772 [A/T] Leu1677Ile 0.38 0.44 A 1.29 (1.05–1.59) 0.014
rs2297181 [G/A] intron 16 0.11 0.12 G 1.07 (0.78–1.46) 0.681
rs1330363 [A/G] intron 15 0.45 0.38 G 1.31 (1.07–1.60) 0.008
rs17819466 [C/T] Thr1525Thr 0.12 0.13 C 1.01 (0.75–1.36) 0.961
rs7865462 [C/T] intron 13 0.44 0.50 C 1.27 (1.04–1.55) 0.018
rs3789873 [C/G] intron 10 0.32 0.25 G 1.41 (1.14–1.74) 0.002
aNucleotides indicated in brackets [major/minor allele].
bOdds ratio (OR) with 95% confidence interval (CI) as well as P-value (x2 test) for differences in allele frequencies between cases and controls.
cP-values 0.05 are marked in bold.
dNumbers may vary slightly between SNPs depending on genotyping success for each SNP.
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it is likely that more genes are involved and interact. The bio-
logical interaction, supported by the genetic interaction,
between NPSR1 and TNC might be one of the factors
leading the disease into a more severe direction and we there-
fore hypothesize that a NPSR1-driven upregulation of TNC
mRNA might increase the severity of asthma- and
allergy-related traits. This hypothesis is supported by the
detection of NPSR1 and TNC upregulation in bronchial
tissue in asthmatic airways, as well as by the proximity of
the expression, where NPSR1 is over-expressed in the epi-
thelial cells and TNC in the sub-epithelial basal membrane
(Fig. 2). A possible mode of action might be that a stimulation
and upregulation of NPSR1 on the surface of the epithelial
cells enhances the epithelial cell production of TNC, and
TNC is then secreted into the sub-epithelial basal membrane.
Several studies have indicated upregulation of TNC by
various Th2 cytokines (27–30). Our results extend this view
by proposing upregulation through a possible new mechanism
that might help to merge the roles of both NPSR1 and TNC in
asthma- and allergy-related disorders.
Studying the PARSIFAL group of children, well character-
ized for asthma- and allergy-related disorders (26), we found
that TNC is not only a biomarker for asthma and inflammation
but also genetically associated to childhood rhinocon-
junctivitis. Previously performed genome-wide linkage
studies on allergic rhinitis have pointed towards the chro-
mosomal region around 9q33, where TNC is located, but
little is still known about underlying genetic mechanisms in
Table 2. Genetic association between TNC haplotypes and current rhinoconjunctivitis in children from the PARSIFAL study
Block Haplotype Estimated haplotype frequency ORa (95% CI) Empirical P-valueb
Cases, n ¼ 214 Controls, n ¼ 2855
1 TGCT 0.39 0.43 0.84 (0.69–1.03) 0.117
CGCC 0.27 0.29 0.89 (0.72–1.12) 0.329
TGGT 0.29 0.21 1.49 (1.20–1.86) 0.0005
TAGT 0.04 0.05 0.81 (0.50–1.30) 0.329
cGlobal empirical P-value ¼ 0.024
2 GA 0.62 0.56 1.29 (1.05–1.58) 0.013
GT 0.35 0.38 0.84 (0.69–1.04) 0.117
AT 0.03 0.05 0.57 (0.32–1.00) 0.040
cGlobal empirical P-value ¼ 0.032
3 GACTC 0.44 0.50 0.80 (0.65–0.97) 0.049
GGCCG 0.31 0.25 1.39 (1.12–1.72) 0.002
GGTCC 0.12 0.13 0.98 (0.72–1.32) 0.702
AACCC 0.11 0.12 0.92 (0.68–1.26) 0.436
cGlobal empirical P-value ¼ 0.040
aORs were calculated with the haplo.cc function included in the R package haplo.stats (http://www.R-project.org). Each analysis compares the
designated haplotype to all others combined.
bEmpirical P-value was estimated by randomized x2 tests (50 000 permutations) for differences in haplotype distribution in cases versus controls using the
haplo.score function, haplo.stats. P-values 0.05 are marked in bold.
cThe global empirical P-value was obtained from the Max-Stat simulation indicating the number of times a maximum score value for individual haplotypes
exceeds the maximum value from the original data.
Table 3. Genotype–genotype interaction between TNC and NPSR1 SNPs. Significant P-valuesa for interactions in either atopic sensitization (to the left) or
doctor’s diagnosis of asthma (to the right)
TNC SNPsb,c NPSR1 SNPsb
rs323917 rs323922 rs324377 SNP546333 rs324384 rs324396 rs740347
rs12347433 0.126: 0.041
rs10817704 0.030: 0.346
rs2104772 0.009: 0.032 0.004: 0.066 0.163: 0.038 0.015: 0.037 0.833: 0.017
rs2297181 0.460: 0.009 0.321: 0.009 0.892: 0.043
rs1330363 0.040: 0.078
rs17819466 0.026: 0.551
rs7865462 0.038: 0.796
rs3789873 0.145: 0.013 0.145: 0.002 0.953: 0.039 0.007: 0.059
Atopic sensitization: Doctor’s diagnosis of asthma.
The P-values indicate whether the effect (OR) of one genotype is altered by effects of another genotype.
aP-values for departure from multiplicative interaction model were obtained by likelihood-ratio tests between the models with and without interaction term.
P-values 0.05 are marked in bold and empty cells represents P . 0.05.
bGenotypes were defined as common homozygous, heterozygous and rare homozygous and a model-free dummy variable approach was used. Due to few rare
homozygotes for some SNPs (indicated by a star ), they were combined with the heterozygous and a dominant genetic model was used.
c4 SNPs for TNC are not included because they did not show any significant interaction (rs12351083, rs1330362, rs13321, rs2274750).
Atopic sensitization, IgE 0.35 kU/L: cases n ¼ 893, controls n ¼ 2203.
Doctor’s diagnosis of asthma: cases n ¼ 261, controls n ¼ 2798.
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rhinoconjunctivitis and few studies trying to identify candidate
genes have been performed up to date (14–16,31–34). We
propose TNC as a candidate gene for childhood rhinoconjuncti-
vitis based on the association seen to several SNPs in the TNC
gene. TNC has previously been indicated to have a role in upper
airway disease (35). We found a risk associated with changing
the TNC rs2104772 A allele Leu1677 into Ile1677, the same
risk allele previously associated to adult asthma (13). The
TNC protein is made up of epidermal growth factor
(EGF)-like repeats, fibronectin type III (FN-III) domains and
a terminal region of a fibrinogen domain. In vivo, six of these
polypeptide chains assemble in the N-termini to form a hexab-
rachion (18). Previously performed protein structure modelling
of TNC revealed that the amino acid replacement Leu1677Ile,
situated in the Fn-III domain, could affect the structural stability
and this was suggested to alter the molecular elasticity of TNC
(13). Intriguingly, the Leu1677Ile variant also showed the most
pronounced role in gene–gene interaction with NPSR1. Yet
a coding SNP rs13321, changing Gln2008 into Glu, showed
significant association to current rhinoconjunctivitis. SNP
rs13321 is positioned in the fibrinogen domain which is situated
at the most distal part of the hexabrachion and influences the
interaction with other proteins (18). An amino acid change
here could possibly lead to an altered ability of TNC to interact
with conjugating proteins.
By permuted haplotype analysis, adjusted for potential con-
founders, we could confirm the single SNP association of TNC
to current rhinoconjunctivitis, both on an individual haplotype
level and on a global level for each haploblock. We showed
that both the 1677Ile variant and the 2008Glu variant were
associated to an increased risk for childhood rhinoconjunctivi-
tis, and that 2008Glu was involved in the risk-associated
haplotype TGGT (P ¼ 0.0005). Both on single SNP and
haplotype level we could see weaker associations to TNC in
children with atopic sensitization and on single SNP level to
doctor’s diagnosis of asthma. As TNC previously has been
associated to adult asthma in a Japanese population (13), we
might have expected to see a stronger association to asthma
in our material. One explanation for the weak association
might be due to the less severe asthmatic phenotype in the
PARSIFAL children compared with the more severe and pro-
longed disease in the Japanese population. This is strength-
ened by our analysis on allergic asthma, which can be
considered as a more specific form of asthma, showing
stronger association than asthma alone. It has also been pro-
posed that there is a link in children between the development
of upper and lower respiratory tract disorders (36) and that
rhinitis is a risk factor for adult-onset asthma (37). Thus,
it is possible that the same TNC SNPs are associated with
rhinoconjunctivitis in children and asthma in adults.
When investigating TNC and NPSR1 SNP interaction, several
significant interactions were seen, particularly for doctor’s
diagnosis of asthma and atopic sensitization. The observed
pattern was that most interactions were found between TNC
rs2104772 (Leu1677Ile) and several of the NPSR1 SNPs and
between NPSR1 rs324384 and several of the TNC SNPs. For
doctor’s diagnosis of asthma, TNC SNPs rs2297181 and
rs3789873 were also found to interact with several of the
NPSR1 SNPs. This interaction pattern can in part be explained
by the tight LD between the SNPs, which might not be
independent of each other. The tagging SNPs in haploblock 2
(rs2104772, Leu1677Ile) and in haploblock 3 (rs3789873),
that showed association to current rhinoconjunctivitis, also
showed a distinct involvement in interaction with NPSR1 for
doctor’s diagnosis of asthma and atopic sensitization.
TNC and NPSR1 showed a complex interaction depending
on the combination of genotypes (Fig. 4 and Supplementary
Material, Table S3A and B). Apparently, TNC genotypes
can be associated with both increased and decreased risk of
disease, depending on NPSR1 genotype status. This phenom-
enon of risk effects being reversed has been described
earlier by Lin et al. (38) and also discussed by Hersh et al.
(6), suggesting that the opposite effect of the SNPs, frequently
observed in replication studies, might be due to gene–gene
and/or gene–environment interactions. Here we can show
that gene–gene interaction plays a role in reversing NPSR1
and TNC risk genotypes. It would be interesting to interpret
the effect of the interactions in vivo, but due to low endogen-
ous NPSR1 expression we have been working with stably or
transiently transfected cell systems. Because the associating
NPSR1 SNPs are intronic and likely regulatory, their inter-
action effects cannot be addressed in transfected cell models.
The PARSIFAL study has a unique design representing
western European children selected on the basis of farming
and anthroposophic lifestyles and their respective reference
groups from rural and sub-urban/urban communities, and
includes exposures relating to different environments known
to influence the development of asthma- and allergy-related
disorders (39,40). Thus we cannot exclude that the environ-
ment plays a role here as well. In this study we have
focused on the overall genetic association and gene–gene
interaction effect across the total sample set rather than inves-
tigating the specific gene–environment effects. Although
Figure 4. Effect of TNC rs2104772 (Leu1677Ile) genotypes Leu/Ile or Ile/Ile
versus Leu/Leu in atopic sensitization (IgE0.35 kU/L), in relation to NPSR1
rs324384 genotypes. Compared with TNC allele Leu/Leu, the TNC Ile/Ile
allele shows a significant increased risk effect if the individual carries the
NPSR1 protective allele CC. If the individual carries the NPSR1 risk allele
TT the TNC risk shows a tendency to diminish. Odds ratio (OR) for Leu/Ile
versus Leu and Ile/Ile versus Leu, respectively (Leu/Leu ¼ 1, baseline)
given NPSR1 rs324384: ‘CC’ 1.18 (0.69–2.02) 1.84 (1.07–3.18), ‘CT’ 0.98
(0.72–1.32) 0.83 (0.60–1.16) and ‘TT’ 0.72 (0.50–1.04) 0.93 (0.63–1.37).
N in the bottom of the picture correspondes to the number of subjects in
each category. P-value for over-all interaction: 0.015.
1678 Human Molecular Genetics, 2008, Vol. 17, No. 11
further studies of the mechanisms behind the TNC and NPSR1
interaction are needed, the observed TNC and NPSR1 inter-
action suggests that certain variants of the genes interact and
affect the development of asthma and allergy.
Asthma is a complex disorder and it is now well established
that many genes are involved genetically in modifying its risk.
Current evidence suggests that asthma risk genes act in a
context-dependent manner, i.e. gene–gene interactions or
gene–environment interaction (41). In the interaction analysis,
the combined TNC and NPSR1 risk effect was clearly different
compared with TNC and NPSR1 individual risk effect, with a
much clearer interaction for atopic sensitization and doctor’s
diagnosis of asthma than for rhinoconjunctivitis. Thus, poly-
morphisms in TNC might play a more independent role for
development of upper airway disease such as rhinoconjuncti-
vitis, whereas for asthma, the interplay with other genes,
like NPSR1, becomes more prominent.
In summary, we here show that the asthma candidate gene
TNC, previously thought of chiefly as a phenotypic marker
for inflammation, also contributes to the genetic risks for
asthma and allergy in childhood. We provide an example of
gene–gene interactions that is supported both by evidence of
a direct biological regulatory effect of one gene by the
other, and by joint analysis of combined genetic risk effects.
Our results suggest that NPSR1, its ligand NPS and TNC
are members of a new pathway for the development of asth-
matic and allergic disorders.
MATERIALS AND METHODS
Cell culture, RNA isolation and cDNA synthesis
Stable human epithelial kidney (HEK) -293H, NPSR1-A over
expressing cell line has been described elsewhere (42). The
cells were cultured in 293 SFM II medium (Gibco/Invitrogen)
supplemented with penicillin/streptomycin and constantly cul-
tured under puromycin selection (0.8 mg/ml) (Sigma-Aldrich,
St Louise, MO, USA). For dose–response experiments, cells
were seeded at 1  106 cells/ml and stimulated with 0.1, 1
or 5 mM NPS (SFRNGVGTGMKKTSFQRAKS) (MedProbe,
Oslo, Norway) for 6 h. Unstimulated control samples were
collected in parallel. Human epithelial lung cells (A549) (a
kind gift from Dr Sam Okret) were cultured in F-12/
D-MEM medium (1:1; Gibco/Invitrogen) supplemented with
fetal calf serum, L-glutamine and penicillin/streptomycin.
Cells were seeded at 0.2  106 cells/ml before transient trans-
fection (LipofectaminTM2000 Reagent, Invitrogen, Carlsbad,
USA) with NPSR1-A constructs (42). Twenty-four hours
after transfection the cells were stimulated with 0.1 mM NPS
for 6 h. Unstimulated control samples were collected in paral-
lel. All cells were cultured at 378C in a humified 5% CO2 incu-
bator. Total cellular RNA was isolated with the RNAeasy
Mini Kit (Qiagen, Hilden, Germany). Reverse transcription
was for HEK-293H cells performed with TaqMan reverse
transcription reagents (Applied Biosystems, Rotkreuz,
Switzerland) using random hexamers and for A549 cells
performed with iScript (Biorad, Hercules, USA) with a oligo
(dT) and random primer mix, according to the manufacturer’s
protocol.
Quantitative real-time PCR
The mRNA expression was measured with qRT–PCR using
SYBRw Green for TNC (primers: fwd TGCGGTCCAGTT-
GAGTCTGA and rev TGTGAAGGCATCCACTGAACA)
and TaqManw for the GAPDH control (primers and probe
from Applied Biosystems). For A549 cells HPRT (primers:
fwd TCAGGCAGTATAATCCAAAGATGGT and rev
AGTCTGGCTTATATCCAACACTTCG) was also used
side-by-side with GAPDH as an endogenous control to
verify the stability of GAPDH. The PCR assay was performed
in a total volume of 25 ml, containing 1:10 diluted cDNA tem-
plate, 12.5 ul SYBRw Green PCR Master Mix (Applied Bio-
systems), 200 nM of each primer and 100 nM of GAPDH
probes, using 7500 Fast Real-Time PCR system (Applied Bio-
systems) with the following reaction conditions: 508C for
2 min and 948C for 10 min; following 45 cycles of 928C for
14 s and 1 min at 608C. A dissociation stage was added to
the SYBRw Green reactions to confirm primer specificity.
All assays were carried out in triplicate. Relative quantifi-
cation and calculation of the range of confidence was per-
formed with the comparative DDCT method (43). Results
are shown as relative expression compared with unstimulated
cells and GAPDH (Applied Biosystems) was used as an
endogenous control.
Immunohistochemistry
Bronchial biopsy specimens were obtained from at least eight
adult normal control subjects and eight asthmatic patients. The
severity of asthma was from mild-to-moderate based on their
medication, lung function results and bronchial hyper respon-
siveness to histamine. The patients had no respiratory tract
infections or asthma exacerbation within 4 weeks before
taking the biopsies and no smoking history for at least 2
years. All patients gave their informed consent for the study.
The biopsies were, for TNC stainings, snap-frozen in liquid
nitrogen before embedded in Tissue Tek, ornityl carbamyl
transferase as previously described (10) and for NPSR1 stain-
ings, formalin fixed and paraffin-embedded. Immunostaining
was performed using a monoclonal antibody 100EB2 for
TNC (44) before incubated with FITC-coupled sheep anti-
mouse IgG (Jackson Immunosearch Laboratories, West Grove,
PA). Sections were then examined under a Leitz Aristoplan
fluorescence microscope. For NPSR1, polyclonal rabbit anti-
bodies for the 2B isoform (1) were used together with the
ABC method (Vectastain Elite ABC kit, Vector Laboratories,
Burlingham, CA). Negative controls were obtained by omission
of the primary antibody, by replacement with an irrelevant mAb
or staining with preimmune sera.
Study design
The cross-sectional PARSIFAL study includes 14 893 school
children 5–13 years from five western European countries
(26). The PARSIFAL study was originally designed to inves-
tigate the role of different lifestyles and environmental
exposures in farm children, Steiner school children (who
often have an anthroposophic lifestyle) and two corresponding
rural and urban/suburban reference groups, respectively.
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The aim was to identify protective factors for development of
asthma and allergic disorders, and hence, the PARSIFAL chil-
dren are well characterized for these traits. In the present study
3113 children with available DNA and consent for genetic
analysis (1579 boys and 1534 girls) were included. Ethical
approval for the study, including genetic analyses, was
obtained in each country according to law.
All health outcomes were reported in questionnaires by the
parents, except for atopic sensitization, which was assessed
from blood sampled from the children. Current rhinoconjunc-
tivitis symptoms were defined as sneezing, runny nose, nasal
block-up and itchy eyes in the child during the last 12
months without having a cold at the same time. A doctor’s
diagnosis of asthma was considered to be present for children
reporting ever having been diagnosed with asthma, or with
obstructive bronchitis more than once. Current wheezing
was defined as at least one episode of wheezing during the
last 12 months and current atopic eczema if the child had
ever had an itchy rash intermittently for at least 6 months
and, in addition, reported an itchy rash at any time during
the last 12 months. Atopic sensitization was defined as at
least one allergen-specific serum IgE test0.35 kU/L against
a mixture of common inhalant (Phadiatopw) and common
food allergens (fx5w) (ImmunoCAPTM, Phadia AB, Uppsala,
Sweden), respectively. Allergic rhinoconjunctivitis was
defined as current rhinoconjunctivitis as described earlier,
in combination with sensitization to inhalant allergens
(Phaditopw) and allergic asthma was defined as those having
a doctor’s diagnosis of asthma in combination with sensitiz-
ation to inhalant allergens.
SNP selection and genotyping
Eighteen SNPs were selected, localized in the mid to the 30
end of TNC based on a previous study (13) and HapMap
CEU LD-pattern (http://www.hapmap.org/), using the Tagger
algorithm implemented in Haploview, with the LD correlation
parameter set to 3.2 r2.0.8 (http://www.broad.mit.edu/mpg/
haploview/) (45). Based on association results from the litera-
ture (rs2104772) (13) and/or coding properties (rs13321,
rs12347433, rs2274750, rs17819466) five SNPs were forced
into the Tagger selection. Thirteen SNPs were the picked for
genotyping since they captured and tagged more than two
nearby SNPs or obtained coding properties (Supplementary
Material, Table S1).
Primers for multiplex PCR and extension reactions were
designed by the SpectroDesigner software (Sequenom
GmbH, San Diego, CA, USA) (Supplementary Material,
Table S1). PCR and extension reactions were performed
according to manufacturer’s standard protocols. The SNP
analysis was performed by MALDI-TOF mass spectrometry
(matrix-assisted laser desorption/ionisation-time of flight;
Sequenom GmbH). Each assay was validated using 24 unre-
lated Caucasians and 3 CEPH DNA samples as well as 14
trios from the CEU population. Based on no significant devi-
ation from Hardy–Weinberg equilibrium (P . 0.05 using x2
test) and a genotyping success rate above 95% (with the
exception of rs3789873 which was accepted with a genotyping
success rate of 88%), 12 SNPs were accepted after the vali-
dation run and used for genotyping. Due to a plate failure,
360 individuals had missing data for rs12347433. Five of the
12 genotyped SNPs are situated in introns, five in coding
regions and two in the 30 genomic region. SNP selection and
genotyping of NPSR1 in the PARSIFAL material is given else-
where (3) but briefly seven tagging SNPs (rs323917, rs323922,
rs324377, SNP546333, rs324384, rs324396 and rs740347)
reported in the Laitinen et al. study (1) where chosen in the
conserved haplotype block of NPSR1. The SNP analysis was
performed as described earlier.
Statistical analyses
Allelic association was analysed for cases versus controls in
Haploview 3.2 (45) using x2-test. Odds Ratios (OR) and
95% Confidence Intervals (CI) were calculated. Block-wise
inheritance of the 12 markers was estimated using the LD
measure D’ in Haploview 3.2 (45). Haplotype association
was tested in the statistical software ‘R’ (http://www.
R-project.org) (46) using the haplo.score algorithm
implemented in the haplo.stats package (47). A permutation
test procedure where haplotypes were treated as fixed while
the disease association status (case or control) is randomized
was used to estimate both the empirical P-value for each hap-
lotype frequency and the global empirical P-value for the
whole haplotype set distribution. The proportion of 50 000
such randomized x2-tests where a stronger association was
found than in the actual data provided the empirical P-value
of the observation. Adjustment was made for the covariates
country-of-origin, sampling group (farm children, Steiner
school children and the corresponding reference groups) and
sex. Haplotype frequencies in cases and controls, as well as
association OR and 95% CI were estimated with the
haplo.cc function (haplo.stats) without adjustment for covari-
ates. The frequency of each haplotype in cases versus controls
was compared with the combined frequency of all other
assigned haplotypes in cases versus controls in each respective
block. All analyses of the haplotype block structure grouping
all 12 SNPs were made in Haploview 3.2.
A multiple logistic regression model was used to test for
gene–gene interaction between TNC and NPSR1 SNPs by
adding an interaction term between the genotypes of interest,
using STATA (Statistical Software, Version 8.0, Collage
Station, TX, and USA). TNC and NPSR1genotypes were
defined as common homozygous, heterozygous and rare
homozygous. A genetic model-free coding with indicator
(dummy) variables for heterozygote and defined common
homozygote genotypes (versus rare homozygote) was used
as a first approach to investigate the pattern of interaction
between TNC and NPSR1 genotypes. For those SNPs where
the rare homozygotes were too few, they were combined
with the heterozygotes and a dominant genetic model was
used. P-values for departure from a multiplicative interaction
model on the OR scale were obtained by likelihood-ratio
tests between the models with and without interaction term.
The global significance of the interaction was tested by a per-
mutation test where the genotypes were held constant and the
disease association status was permuted 1000 times. The
regression models were adjusted for the potential confounders;
country-of-origin, sampling group and sex.
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